| Gene symbol | WT1 | Synonyms | AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | WT1 transcription factor | ||||
| GTO ID | GTC0311 |
| Trial ID | NCT02770820 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | WT1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | WT1 TCR-T cells |
| HLA | HLA-A*02:01 |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | Phase I/II Study of Autologous (Central Memory/Naïve) CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor for Treatment of AML |
| Year | 2016 |
| Country | United States |
| Company sponsor | Fred Hutchinson Cancer Center |
| Other ID(s) | 9296|NCI-2016-00042|9296|P01CA018029|P30CA015704|RG9216011 |
| Cohort 1 | |||||||||||||
|
|||||||||||||